Integrity in Science
Return to CSPI U.S.
Search the Database
About the Integrity
in Science Project
Project Activities
Promoting Disclosure
Challenging Conflicts of Interest
National Conference
Reports
IIS Watch
IIS Watch Archives
Press Releases
Resources
National Conference
Contact Us

Challenging Conflicts of Interest

To guard against corporate-funded and/or questionable science dominating the regulatory process, the Integrity in Science project selectively investigates and reports on the make-up of the federal government’s more than 1,000 scientific advisory committees. The project also selectively monitors and issues reports about key non-government advisory bodies like the National Academies of Science, which Congress and regulatory agencies often turn to for advice.

Because these advisory committees provide critical guidance and scientific information for government agencies charged with protecting the public health and safety, it is imperative that these committees meet all the fairness and balance requirements of the Federal Advisory Committee Act. Every member of these committees must disclose conflicts of interest to the general public.

The Integrity in Science project challenges committee members who have represented corporations with a stake in the outcome of a scientific study or regulatory proceeding. When such members are appointed to committees for their scientific expertise, the project also intervenes to ensure that equal representation is given to independent scientists and representatives of the public interest.

EPA Advisory Committees

Are the National Academies Fair and Balanced?: One in Five Scientists on NAS Issue Panels Tied to Firms Involved in Issue
July 24, 2006

CSPI, Environmental Working Group Challenge Two Scientists on EPA panel: Committee on Teflon Toxic Larded with Industry Scientists
December 9, 2004

FDA Advisory Committees

Despite Official Spin, Report Shows FDA Can Easily Find Experts Without Conflicts of Interest: Science Groups Urge Agency to Adopt Restrictions on Conflicted Experts
December 3, 2007

The Best Advice is Free From Conflicts of Interest: Statement of CSPI Integrity in Science Director Merrill Goozner on S.3807
November 15, 2006

Are the National Academies Fair and Balanced?: One in Five Scientists on NAS Issue Panels Tied to Firms Involved in Issue
July 24, 2006

FDA Panel Investigating Labeling of Antihypertensive Drugs Stacked with Industry Consultants: Draft Guidance May Miss Opportunity to Educate Americans About Importance of Lifestyle, Diet on High Blood Pressure
April 24, 2006

Senate Votes to Require Greater Transparency on Conflicts of Interest at FDA: Statement of CSPI Integrity in Science Director Merrill Goozner
September 21, 2005

FDA Lets Scientists With Drug Company Ties Evaluate New Insulin Product
September 9, 2005

House Votes to Prohibit Financial Conflicts of Interest on FDA Panels: Statement of CSPI Integrity in Science Director Merrill Goozner
June 8, 2005

CSPI Calls for Replacement of Member of Breast Implant Panel: Statement of CSPI Integrity in Science Project Director Merrill Goozner
April 6, 2005

CSPI Urges Removal of FDA Panelists on SSRIs
February 2, 2004

NAS Advisory Committees

Are the National Academies Fair and Balanced?: One in Five Scientists on NAS Issue Panels Tied to Firms Involved in Issue
July 24, 2006

Groups Urge Removal of Logging Executive from Forestry Panel: Weyherhaeuser Has Obvious Financial Conflict of Interest, Groups Say
March 21, 2006

NAS Coal Combustion Appointees Off Committee: Panel Still Consists of Several Members With Industry Ties
November 12, 2004

NAS Panel Rife with Undisclosed Financial Ties to Polluters: Watchdog Groups Call for Removal of Mining Co. Reps.
January 22, 2004

CSPI Reaction to IOM Report on Food Labeling
December 11, 2003

USDA Advisory Committees

Dietary Guidelines Committee Criticized: CSPI Calls for Replacement of Members with Tightest Corporate Ties
August 19, 2003

WHO/IARC Advisory Committees